These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1569817

  • 1. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ, Ejigu M, Haile-Mariam HS, Berhan TY, Tasesse G.
    Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V, Prata RB, Barbosa MG, Mendes MA, Brandão SS, Amadeu TP, Rodrigues LS, Ferreira H, Costa Fda M, Dos Santos JB, Pacheco Fdos S, Machado Ade M, Nery JA, Hacker Mde A, Sales AM, Pinheiro RO, Sarno EN.
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [Abstract] [Full Text] [Related]

  • 3. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
    Haslett PA, Roche P, Butlin CR, Macdonald M, Shrestha N, Manandhar R, Lemaster J, Hawksworth R, Shah M, Lubinsky AS, Albert M, Worley J, Kaplan G.
    J Infect Dis; 2005 Dec 15; 192(12):2045-53. PubMed ID: 16288366
    [Abstract] [Full Text] [Related]

  • 4. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY, Achirafi A, Flageul B.
    Acta Leprol; 2003 Dec 15; 12(3):117-22. PubMed ID: 15040702
    [Abstract] [Full Text] [Related]

  • 5. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C.
    Lepr Rev; 1988 Jun 15; 59(2):184-5. PubMed ID: 3246930
    [No Abstract] [Full Text] [Related]

  • 6. A review of thalidomide's history and current dermatological applications.
    Perri AJ, Hsu S.
    Dermatol Online J; 2003 Aug 15; 9(3):5. PubMed ID: 12952752
    [Abstract] [Full Text] [Related]

  • 7. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS, Fraga LR, Kowalski TW, Daxbacher ELR, Schuler-Faccini L, Vianna FSL.
    Acta Trop; 2018 Jul 15; 183():134-141. PubMed ID: 29474830
    [Abstract] [Full Text] [Related]

  • 8. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L, Scollard DM, Theetranont C, Chiewchanvit S, Nelson DL, Utaipat U.
    Asian Pac J Allergy Immunol; 1991 Dec 15; 9(2):107-19. PubMed ID: 1807258
    [Abstract] [Full Text] [Related]

  • 9. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B, Pallapati MS, Tarwater P, Srikantam A.
    PLoS Negl Trop Dis; 2020 Oct 15; 14(10):e0008678. PubMed ID: 33035210
    [Abstract] [Full Text] [Related]

  • 10. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P, Venkatesan S, Sivashanmugam E, Showkath Ali MK.
    Indian J Pharmacol; 2019 Oct 15; 51(1):72-74. PubMed ID: 31031470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
    Pacheco FS, Prata RBDS, Brandão SS, Ferreira H, Rodrigues TF, Brandão Dos Santos J, da Silva CO, Tavares IF, Mendes MA, Rodrigues ACDP, Machado AM, Nery JADC, Amadeu TP, Moraes MO, Sarno EN, Schmitz V.
    Immunohorizons; 2020 Feb 07; 4(2):47-56. PubMed ID: 32034084
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
    Sampaio EP, Kaplan G, Miranda A, Nery JA, Miguel CP, Viana SM, Sarno EN.
    J Infect Dis; 1993 Aug 07; 168(2):408-14. PubMed ID: 8335978
    [Abstract] [Full Text] [Related]

  • 15. Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.
    Martiniuk F, Giovinazzo J, Tan AU, Shahidullah R, Haslett P, Kaplan G, Levis WR.
    J Drugs Dermatol; 2012 May 07; 11(5):626-30. PubMed ID: 22527432
    [Abstract] [Full Text] [Related]

  • 16. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
    Darlong J, Govindharaj P, Charles DE, Menzies A, Mani S.
    Lepr Rev; 2016 Jun 07; 87(2):211-20. PubMed ID: 30212168
    [Abstract] [Full Text] [Related]

  • 17. Thalidomide in the treatment of leprosy.
    Teo S, Resztak KE, Scheffler MA, Kook KA, Zeldis JB, Stirling DI, Thomas SD.
    Microbes Infect; 2002 Sep 07; 4(11):1193-202. PubMed ID: 12361920
    [Abstract] [Full Text] [Related]

  • 18. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B, Sardana K, Kumari R, Khurana A, Sinha S, Sachdeva S.
    Am J Trop Med Hyg; 2021 Oct 18; 106(1):51-53. PubMed ID: 34662871
    [Abstract] [Full Text] [Related]

  • 19. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC.
    Pharmacotherapy; 2003 Apr 18; 23(4):481-93. PubMed ID: 12680478
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.